Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease. (Q50905263)
Jump to navigation
Jump to search
scientific article published in February 1998
Language | Label | Description | Also known as |
---|---|---|---|
English | Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease. |
scientific article published in February 1998 |
Statements
1 reference
Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease. (English)
1 reference
Garnero P
1 reference
Gineyts E
1 reference
Schaffer AV
1 reference
Seaman J
1 reference
Delmas PD
1 reference
1 February 1998
1 reference
41
1 reference
2
1 reference
354-360
1 reference
Identifiers
1 reference